2-(Piperidin-3-yl)ethanol hydrochloride, 95.0%, 25g

7-Methylquinolin-8-amine, 95.0%, 10g

4-Methyltetrahydro-2H-pyran-4-amine hydrochloride, 95.0%, 10g

4,4?,4?,4??-(Porphine-5,10,15,20-tetrayl)tetrakis(benzenesulfonic acid), 97%, 250mg

1,6-esandiolo, >=96%, per sintesi, 250 g, confezione in plastica.

2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)-, 98%, 25mg

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 5g

1,3,5,7-tetrakis(4-iodophenyl)adamantane, 97%, 250mg

[(cyclohexylmethyl)sulfanyl]methanimidamide hydrobromide, 95.0%, 2g

(2-Isopropoxypyridin-3-yl)boronic acid, 95.0%, 5g

N-Benzyl-3-pyrrolidinone, 97.0%, 25g

5-Bromo-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one, 95.0%, 25g

2-Chloroethylurea>98.0%(N)25g